K
Keros Therapeutics D
D
KROS
11.130
USD
0.03
(0.27%)
مغلق
حجم التداول
10,729
الربح لكل سهم
-6
العائد الربحي
-
P/E
5
حجم السوق
220,238,626
المقالات
العنوان: Keros Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.